Primary treatment of an indirect carotid cavernous fistula by injection of N-butyl cyanoacrylate in the dural wall of the cavernous sinus

Ali Shaibani, Mehdi Rohany*, Richard Parkinson, John K. Hopkins, H. Hunt Batjer, Guilherme Dabus, Kamron Izadi, Eric J. Russell

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background: Carotid cavernous fistulae are abnormal communications between the carotid artery system and the cavernous sinus. Endovascular treatment is the treatment of choice, but because of their heterogeneous etiology and anatomy, an appropriate treatment plan must be tailored for each patient. Case Description: A 77-year-old diabetic woman presented with rapid onset of right eye pain, conjunctivitis, and chemosis. Angiography revealed an indirect CCF located in the posterior wall of the right cavernous sinus. N-Butyl cyanoacrylate was injected directly into the fistula site in the dural wall via a microcatheter, resulting in a cure. Conclusion: We describe an unconventional treatment of an indirect CCF from an IPS approach. One type D2 CCF was treated successfully using only N-butyl cyanoacrylate injected directly at the fistula site. This was achieved by microcatheterization of the fistula in the posterior wall of the right cavernous sinus.

Original languageEnglish (US)
Pages (from-to)403-408
Number of pages6
JournalSurgical Neurology
Volume67
Issue number4
DOIs
StatePublished - Apr 2007

Keywords

  • Carotid-cavernous sinus fistula
  • Cyanoacrylates
  • Embolization
  • Intracranial arteriovenous malformations
  • Therapeutic

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Fingerprint

Dive into the research topics of 'Primary treatment of an indirect carotid cavernous fistula by injection of N-butyl cyanoacrylate in the dural wall of the cavernous sinus'. Together they form a unique fingerprint.

Cite this